Abstract
To the Editor: Hart et al. (June 7 issue)1 report the results of the NAVIGATE ESUS (New Approach Rivaroxaban Inhibition of Factor Xa in a Global Trial versus ASA to Prevent Embolism in Embolic Stro...
Cite
CITATION STYLE
APA
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source. (2018). New England Journal of Medicine, 379(10), 986–987. https://doi.org/10.1056/nejmc1809065
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free